Raymond James downgraded Dipexium Pharmaceuticals (NASDAQ: DPRX) from Outperform ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Downgrades

Dipexium Pharma (DPRX) will resume trading at 7:30am ETOctober 25, 2016 7:11 AM Dipexium Pharma (DPRX) Announces Locilex Phase 3s Missed Primary EndpointsOctober 25, 2016 7:04 AM Dipexium Announces Top-line Data from OneStep Phase 3 Trials with Locilex® in Mild Diabetic Foot Infection Did Not Meet Primary Clinical Endpoint of Superiority Versus Vehicle Plus Standardized WoundOctober 25, 2016 7:01 AM Dipexium Pharma (DPRX) trading halted with news pendingOctober 25, 2016 6:56 AM